These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2617480)

  • 1. Analysis of serum cancer procoagulant activity and its possible use as a tumor marker.
    Gordon SG; Benson B
    Thromb Res; 1989 Nov; 56(3):431-40. PubMed ID: 2617480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer procoagulant in serum of rats during development of experimental epithelioma.
    Mielicki W; Wierzbicki R
    Int J Cancer; 1990 Jan; 45(1):125-6. PubMed ID: 2298496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of cancer procoagulant as an early detection tumor marker.
    Kozwich DL; Kramer LC; Mielicki WP; Fotopoulos SS; Gordon SG
    Cancer; 1994 Aug; 74(4):1367-76. PubMed ID: 8055461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancer procoagulant activity in serum and neoplastic tissue in cases of cervical and uterine carcinoma].
    Szajda SD; Jóźwik M; Jóźwik M; Zalewska B; Panek G; Sulkowski S; Skrzydlewski Z
    Ginekol Pol; 2004 Sep; 75(9):705-12. PubMed ID: 15600294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activity of cancer procoagulant in cases of uterine leiomyomas.
    Jozwik M; Szajda SD; Skrzydlewski Z; Jozwik M; Sulkowski S
    Eur J Gynaecol Oncol; 2005; 26(4):407-10. PubMed ID: 16122189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of cancer procoagulant (CP) in serum of patients with cancer of lung, breast, oesophagus and colorectum.
    Rucińska M; Furman M; Skrzydlewski Z; Zaremba E
    Acta Biochim Pol; 1997; 44(1):109-12. PubMed ID: 9241361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer procoagulant in patients with adenocarcinomas.
    Kaźmierczak M; Lewandowski K; Wojtukiewicz MZ; Turowiecka Z; Kołacz E; Lojko A; Skrzydlewska E; Zawilska K; Komarnicki M
    Blood Coagul Fibrinolysis; 2005 Nov; 16(8):543-7. PubMed ID: 16269926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new procoagulant in acute leukemia.
    Falanga A; Alessio MG; Donati MB; Barbui T
    Blood; 1988 Apr; 71(4):870-5. PubMed ID: 3355894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics.
    Falanga A; Bolognese Dalessandro AP; Casali B; Roncaglioni MC; Donati MB
    Int J Cancer; 1987 Jun; 39(6):774-7. PubMed ID: 3294610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer procoagulant in human tumor cells: evidence from melanoma patients.
    Donati MB; Gambacorti-Passerini C; Casali B; Falanga A; Vannotti P; Fossati G; Semeraro N; Gordon SG
    Cancer Res; 1986 Dec; 46(12 Pt 1):6471-4. PubMed ID: 3536081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procoagulant factors in patients with cancer.
    Molnar S; Guglielmone H; Lavarda M; Rizzi ML; Jarchum G
    Hematology; 2007 Dec; 12(6):555-9. PubMed ID: 17852460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer procoagulant as a marker in monitoring the therapy in cases of oesophageal, stomach and colorectal cancer.
    Kozuszko B; Skrzydlewska E; Snarska J; Kozłowski M; Zalewski B; Skrzydlewski Z
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():104-5. PubMed ID: 11820560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer procoagulant in acute lymphoblastic leukemia.
    Alessio MG; Falanga A; Consonni R; Bassan R; Minetti B; Donati MB; Barbui T
    Eur J Haematol; 1990 Aug; 45(2):78-81. PubMed ID: 2209822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cancer procoagulant and cathepsin D activity in blood serum in patients with bladder cancer].
    Szajda SD; Darewicz B; Kudelski J; Chlabicz M; Domel T; Chabielska E; Skrzydlewski Z
    Pol Merkur Lekarski; 2005 Jun; 18(108):651-3. PubMed ID: 16124376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of examination of some tumor markers in diagnostics of liver cancer.
    Snarska J; Szajda SD; Puchalski Z; Szmitkowski M; Chabielska E; Kaminski F; Zwierz P; Zwierz K
    Hepatogastroenterology; 2006; 53(68):271-4. PubMed ID: 16608038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of detecting cancer procoagulant activity and thyrotropic hormone concentration in the differentiation of tumor-like changes in the thyroid].
    Snarska J; Szajda SD; Knaś M; Mroczko B; Borzym-Kluczyk M; Kamiński F; Zwierz P; Zwierz K
    Wiad Lek; 2006; 59(5-6):332-5. PubMed ID: 17017477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cancer procoagulant--biochemical characteristics and the influence on the development of neoplastic disease].
    Kamocka M; Mielicki WP
    Postepy Biochem; 2003; 49(3):168-74. PubMed ID: 15083609
    [No Abstract]   [Full Text] [Related]  

  • 18. Generation of a monoclonal antibody that inhibits the procoagulant activity of various cancer cell lines.
    Inufusa H; Adachi T; Suzuki M; Ando O; Ohta T; Kurimoto M; Nakatani Y; Nakamura M; Yasutomi M
    Cancer; 1998 Apr; 82(8):1563-9. PubMed ID: 9554535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proteolytic procoagulant associated with malignant transformation.
    Gordon SG
    J Histochem Cytochem; 1981 Mar; 29(3A Suppl):457-63. PubMed ID: 7016982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary characterization of the procoagulant material in human ascites.
    Addonizio VP; Fisher CA; Strauss JF; Ewan VA; Rickles FR; Rosato EF; Harken AH; Inouye WY
    Surgery; 1987 Jun; 101(6):753-62. PubMed ID: 3589968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.